Table 3.
Risk factors of diagnosis with a psychotic disorder in narcoleptic patients.
| Variables | Psychotic disorder | ||
|---|---|---|---|
| n (%) | aOR (95% CI) | P-value | |
| Age at recruitment | – | 1.00 (0.98–1.03) | 0.755 |
| Gender | |||
| Male (N = 140) | 12 (8.6) | 1 | |
| Female (N = 118) | 9 (7.6) | 1.00 (0.38–2.66) | 1.000 |
| ADHD | |||
| Without (N = 235) | 16 (6.8) | 1 | |
| With (N = 23) | 5 (21.7) | 1.21 (0.26–5.59) | 0.812 |
| ASD | |||
| Without (N = 252) | 18 (7.1) | 1 | |
| With (N = 6) | 3 (50.0) | 10.42 (1.40–77.52) | 0.022* |
| Intellectual disability | |||
| Without (N = 252) | 19 (7.5) | 1 | |
| With (N = 6) | 2 (33.2) | 3.25 (0.38–27.68) | 0.280 |
| Epilepsy | |||
| Without (N = 235) | 17 (7.2) | 1 | |
| With (N = 23) | 4 (17.4) | 2.02 (0.53–7.67) | 0.302 |
| Methylphenidate | |||
| Without (N = 151) | 9 (6.0) | 1 | |
| With (N = 107) | 12 (11.2) | 2.39 (0.83–6.86) | 0.106 |
| Modafinil | |||
| Without (N = 224) | 19 (8.5) | 1 | |
| With (N = 34) | 2 (5.9) | 0.59 (0.11–3.04) | 0.528 |
ADHD, attention-deficit hyperactivity disorder; ASD, Autism Spectrum Disorder; aOR, adjusted odds ratios; 95% CI, 95% confidence interval; n, number of diagnosed psychotic disorders. *P < 0.05.